Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(25%)
Results Posted
33%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Recruiting2
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (25.0%)
N/A6 (75.0%)

Trials by Status

recruiting225%
completed338%
not_yet_recruiting113%
terminated113%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8